Aprotinin Use In Patients Undergoing Thoracoabdominal Aneurysmectomy
— · The Internet Journal of Surgery · 2000
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
The Internet Journal of Surgery · OpenAlex · article · 2000
Abstract
Aprotinin is a serine proteinase inhibitor able to preserve adhesive glycoprotei ns in the platelet membranes. In addition, it inhibits fibrinolysis and inflamma tory cascades that might be in part responsible for the high incidence of compli cations accompanying aortic cross-clamping (1). Aprotinin has shown to be very e ffective in reducing blood loss in patients undergoing aortic surgery (2,3). However, it has the potential to damage the renal sy stem. This effect seems to be dose-dependant. The use of aprotinin in aortic sur gery is therefore still controversial. No study has yet analyzed the costs-benef its of aprotinin in patients undergoing TAAA repair.
Our goal was to evaluate th e economic consequences and efficacy and to establish the renal safety of low-do se aprotinin in this high-risk patient population.
Open the resolved locator · 10.5580/72a
Metadata licence: OpenAlex metadata (CC0)